ClinVar Miner

Submissions for variant NM_004656.4(BAP1):c.1026C>T (p.Ser342=)

gnomAD frequency: 0.00304  dbSNP: rs71651686
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 20
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000205453 SCV000261609 benign BAP1-related tumor predisposition syndrome 2024-02-01 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000244636 SCV000310597 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000205453 SCV000445473 benign BAP1-related tumor predisposition syndrome 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000244636 SCV000518946 likely benign not specified 2018-01-19 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000561863 SCV000664582 likely benign Hereditary cancer-predisposing syndrome 2016-11-10 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Color Diagnostics, LLC DBA Color Health RCV000561863 SCV000682546 likely benign Hereditary cancer-predisposing syndrome 2016-03-09 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001172150 SCV001335114 benign not provided 2024-01-01 criteria provided, single submitter clinical testing BAP1: BP4, BS1, BS2
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000205453 SCV001472275 benign BAP1-related tumor predisposition syndrome 2020-02-16 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000244636 SCV002071061 benign not specified 2019-06-19 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000561863 SCV002537240 benign Hereditary cancer-predisposing syndrome 2020-10-22 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000244636 SCV002550824 likely benign not specified 2023-08-15 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000244636 SCV002774068 benign not specified 2021-07-23 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002500656 SCV002811855 likely benign BAP1-related tumor predisposition syndrome; Kury-Isidor syndrome 2021-07-14 criteria provided, single submitter clinical testing
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV003316144 SCV004016327 benign Melanoma, uveal, susceptibility to, 2 2023-07-07 criteria provided, single submitter clinical testing
True Health Diagnostics RCV000561863 SCV000805224 likely benign Hereditary cancer-predisposing syndrome 2018-06-05 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV001172150 SCV001740454 likely benign not provided no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV001172150 SCV001799887 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV001172150 SCV001808346 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001172150 SCV001970594 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000244636 SCV002034117 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.